[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_3031 

# __Uncertainty of vaccine effectiveness, time-consuming research process__

## Category to which it belongs

* [Limited capacity, high demand, waning effectiveness, distribution difficulties, and access disparities hinder efficient vaccination efforts.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_75.md)

## Closest similar item

* [Demand for vaccine development](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1888.md)
* [Difficulty in vaccine distribution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_430.md)
* [Expectations for vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_519.md)
* [Inadequate vaccine efficacy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_861.md)
* [Inefficient use of resources in vaccination process](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_423.md)
* [Lack of knowledge about the virus, treatments, and vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3118.md)
* [Representation and analysis of vaccine candidates](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_41.md)
* [Vaccine access disparities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_156.md)
* [Vaccine availability, vaccine hesitancy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1916.md)
* [Waning efficacy of vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2879.md)

## Mitigations of this risk

* [Increased funding for vaccine research](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_4376.md)

## This Risk belongs to this RiskGroup

* [Economic risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_5.md)

